CyberArk Software (CYBR) PT Raised to $57 at UBS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/10/2026
- Wall Street ends down as expectations of Hormuz deal fade
- JPMorgan lifts S&P 500 target to 8,000 on strong earnings
- Nvidia and Wall Street giants plan $500B AI funding deal, FT reports
- Jefferies cuts Apple rating as higher-priced iPhone roadmap looks difficult
- Oil climbs 5% as Iran, US both demand compensation and Hormuz hopes fade
- After-Hours Movers: P, RIOT, BW, RKLB, HIMS, UPWK
- After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
- After-Hours Movers: SPCX, AMD, ANET, PINS, APPS, UPST, ZETA, BKNG, LCID, CPNG, MTCH
- After-Hours Stock Movers: PLTR, SNAP, ON, ICHR, WGS, WHR
CyberArk Software (CYBR) PT Raised to $63 at Imperial Capital
February 10, 2017 10:48 AM ESTImperial Capital raised its price target on CyberArk Software (NASDAQ: CYBR) to $63.00 (from $55.00) while maintaining a Outperform rating. CYBR reported 4Q16 revenue of $64.4mn and adjusted EPS of $0.41, above Street revenue estimates of 63.0mn and adjusted EPS estimates of $0.33.
Analyst Michael Kim... More
After-Hours Stock Movers 02/09: (INFN) (ATVI) (SWIR) Higher; (RSYS) (TCON) (YELP) Lower (more...)
February 9, 2017 6:31 PM ESTToday's After-Hours Movers
Radisys Corp (NASDAQ: RSYS) 15% LOWER; reported Q4 EPS of $0.04, in-line with the analyst estimate of $0.04. Revenue for the quarter came in at $40.6 million versus the consensus estimate of $42.06 million.
TRACON Pharmaceuticals (NASDAQ: TCON) 12.4% LOWER; reported top-line results from a randomized Phase 2 clinical trial of TRC105 in recurrent glioblastoma (GBM) funded and conducted by the Clinical Therapy Evaluation Program (CTEP) of the National Cancer Institute (NCI). In the trial, TRC105 combined with Avastin® (bevacizumab) was... More
CyberArk Software (CYBR) Tops Q4 EPS by 8c
February 9, 2017 4:12 PM ESTCyberArk Software (NASDAQ: CYBR) reported Q4 EPS of $0.41, $0.08 better than the analyst estimate of $0.33. Revenue for the quarter came in at $64.4 million versus the consensus estimate of $63.01 million.
GUIDANCE:
CyberArk Software sees Q1 2017 EPS of $0.21-$0.23, versus the consensus of... More
